ARA-290 16mg

ARA-290 is a synthetic research peptide engineered from the B-helix domain of erythropoietin. It selectively binds the EPOR–CD131 receptor complex, activating the innate repair receptor (IRR) pathway without stimulating erythropoiesis. Preclinical models show ARA-290 modulates cytokine activity, endothelial integrity, and neuroimmune signaling, making it a tool for studies on inflammation and tissue protection.

For research use only. Not for human consumption.

References:
Brines M et al., Proc Natl Acad Sci USA, 2008 105(31):10925–10930
Ehrenreich H et al., Mol Med, 2010 16(9-10): 440–446
Ostrowski D et al PLoS One, 2017 12(10): e0185838